The latest learning and CPD content on cancer. Under ‘Other resources’ you will find all our other content related to cancer.
CPD and Learning
Cervical cancer prevention: advice and servicesSubscription
With the uptake of cervical screening at 70–73% in the UK, it is important for pharmacy teams to recognise the symptoms of cervical cancer, as well as provide advice on prevention strategies.
Venous thromboembolism is a complication of cancer that pharmacists should understand to ensure that their patients have the best possible outcomes.
Dental caries, periodontal disease and oral cancer are health problems that can be prevented with the help of community pharmacists.
Pharmacists should be able to describe the differences between acute lymphoblastic and chronic lymphocytic leukaemia and the available treatment.
Access to colorectal cancer screening varies across the UK. This article describes the various tests and how community pharmacists can promote them.
This article provides practical advice to support pharmacy professionals in their duty of care to recognise and refer patients with ‘red flag’ cancer symptoms.
Lung cancer: advances in management and therapySubscription
An overview of traditional and emerging immunotherapy-based targets and treatments available for lung cancer, their side effects and the impact immune checkpoint inhibitors have had on the treatment of non–small-cell lung cancer.
These treatments are commonly associated with autoimmune-related side effects and toxicities. This article outlines how pharmacists and the pharmacy team can recognise and manage these adverse events.
Vitamin D may protect against colitis adverse events in patients taking immune checkpoint inhibitorsSubscription
People with melanoma who take immune checkpoint inhibitors are less likely to develop colitis if they are taking vitamin D supplements at treatment initiation, a study published in the journal Cancer has suggested
Immuno-oncology agents for cancer therapySubscription
Abstract: Until recently, cancer therapy comprised of four main types of treatment: surgery, radiotherapy, chemotherapy and targeted therapy. Over the past decade, immuno-oncology (IO) has emerged as a novel and important approach to cancer treatment through the stimulation of the body’s own immune system to kill cancer cells. This newly recognised method of treating cancer is rapidly developing, with many accelerated approvals by the US Food and Drug Administration and European Medicines ...
Lower gastrointestinal bleeding in patients with atrial fibrillation who are being treated with oral anticoagulants is associated with a higher risk of being diagnosed with colorectal cancer, a study published in the European Heart Journal suggests.
Going against type: the new class of cancer therapies targeting mutations rather than tissuesSubscription
‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?
Women who take statins long-term, including those carrying the BRCA1/2 gene mutation, could be less likely to develop ovarian cancer than those who do not, research published in JAMA has suggested.
Measuring patients’ step counts before they receive lung cancer treatment could help predict outcomes, research published in the International Journal of Radiation Oncology, Biology, Physics has suggested.
The efficacy of human papillomavirus vaccines as a preventative for cervical cancer may have been overestimated in trials, a review in the Journal of the Royal Society of Medicine has concluded.
Patients with advanced melanoma treated with a combination of ipilimumab and nivolumab are more likely to be alive five years later than patients treated with ipilimumab alone or nivolumab alone.